Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

The global Neuromodulation Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neuromodulation Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuromodulation Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuromodulation Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuromodulation Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)

Segment by Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other